Live Covid-19 News Updates

Here’s what you need to know: Top U.S. health officials update Congress on vaccine development and distribution plans. Video transcript Back transcript N.I.H. Director Has ‘Cautious Optimism’ for Covid-19 Vaccine by End of 2020 Dr. Francis Collins, the director of the National Institutes of Health, emphasized to senators that coronavirus vaccine development and distribution would…

How the Coronavirus Attacks the Brain

The coronavirus targets the lungs foremost, but also the kidneys, liver and blood vessels. Still, about half of patients report neurological symptoms, including headaches, confusion and delirium, suggesting the virus may also attack the brain. A new study offers the first clear evidence that, in some people, the coronavirus invades brain cells, hijacking them to…

Drugmaker Pauses Covid-19 Vaccine Trial for Safety Review

Here’s what you need to know: ImageLaboratory technicians worked on an experimental coronavirus vaccine developed by Oxford University and AstraZeneca last month.Credit…Natacha Pisarenko/Associated Press AstraZeneca halts a vaccine trial to investigate a participant’s illness. The pharmaceutical company AstraZeneca halted global trials of its coronavirus vaccine on Tuesday because of a serious and unexpected adverse reaction…

Meet the New Caregiver: Your Home

When Kobi Karp, a Miami-based architect, designs one of the sleek, ultramodern homes that have become his trademark, he thinks about arcs and angles. He thinks about how to fill the houses with so much sun that they become light boxes; he considers the Art Deco heritage of South Beach and the influence of its…

Special journal issue features Nemours heart specialists’ best practices for children

JACKSONVILLE, Fla. (September 9, 2020) – The September issue of Progress in Pediatric Cardiology will exclusively feature articles by pediatric cardiologists at Nemours Children’s Health System on echocardiography and other cardiac imaging techniques used in the care of children with cardiovascular disease. The 15 original papers and four case studies highlight best practices for imaging…

Small proteins against SARS-CoV-2 neutralize infection in cell culture

Using innovative computer-based approaches, researchers have developed protein inhibitors that block the interaction between the SARS-CoV-2 virus and human cell receptor ACE2. In cell culture, the most potent of these inhibitors could neutralize virus infection, paving the way for their use in therapies that could be delivered more easily than antibodies. SARS-CoV-2 infection generally begins…

Designed antiviral proteins inhibit SARS-CoV-2 in the lab

Computer-designed small proteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19. The findings are reported today, Sept. 9, in Science In the experiments, the lead antiviral candidate, named LCB1, rivaled the best-known SARS-CoV-2 neutralizing antibodies in its protective actions. LCB1 is currently being evaluated in rodents. Coronaviruses…